We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIMI
7551
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$7 ﹤0.01%
6
-1
-14% -$2
BKYI
7552
BIO-key International
BKYI
$4.28M
0
FGNX
7553
FG Nexus Inc
FGNX
$40.7M
0
PET
7554
DELISTED
Wag!
PET
$6 ﹤0.01%
2
-326
-99% -$911
WINT
7555
DELISTED
Windtree Therapeutics
WINT
0
XELAP
7556
DELISTED
Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
XELAP
$6 ﹤0.01%
+2
New +$7
ARTLW
7557
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$6 ﹤0.01%
162
BXRX
7558
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$6 ﹤0.01%
2
-133
-99% -$796
BIAF icon
7559
bioAffinity Technologies
BIAF
$3.02M
0
FAT
7560
DELISTED
FAT Brands
FAT
$5 ﹤0.01%
2
-2,022
-100% -$7.59K
NRSN icon
7561
NeuroSense Therapeutics
NRSN
$18.1M
$5 ﹤0.01%
4
NTRP icon
7562
NextTrip
NTRP
$22.8M
$5 ﹤0.01%
1
-9
-90% -$113
STAB
7563
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$5 ﹤0.01%
60
+59
+5,900% +$7
AIFA
7564
All In FutureTech Alliance Inc
AIFA
$16.2M
$4 ﹤0.01%
+1
New +$7
CARV
7565
DELISTED
Carver Bancorp
CARV
$4 ﹤0.01%
+1
New +$4
IMCC
7566
IM Cannabis
IMCC
$1.15M
$4 ﹤0.01%
1
JRSH icon
7567
Jerash Holdings
JRSH
$69.6M
$4 ﹤0.01%
1
LGMK
7568
DELISTED
LogicMark
LGMK
-4
Closed -$1.42K
SHFS icon
7569
SHF Holdings
SHFS
$1.14M
0
WORX
7570
DELISTED
SCWORX CORP NEW
WORX
0
NVOS
7571
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$4 ﹤0.01%
+2
New +$7
MOBQ
7572
DELISTED
Mobiquity Technologies, Inc. Common Stock
MOBQ
$4 ﹤0.01%
1
-6
-86% -$96
ALOY
7573
REalloys Inc
ALOY
$879M
$3 ﹤0.01%
+2
New +$4
CDIO icon
7574
Cardio Diagnostics
CDIO
$5.56M
0
LDTCW
7575
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$3 ﹤0.01%
151

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.